LeMaitre Vascular, Inc.'s revenue has grown 14% a year over three years, and grown 12% a year over five, with earnings per share compounding at 36%. Revenue growth, 3-year annual rate: +14% (Medical Instruments & Supplies median +9.4%). Revenue growth, 5-year rate: +12%, growth has picked up over the last three years. Earnings per share, 3-year rate: +36%, earnings outgrew revenue: margins or the share count worked for shareholders. Years of annual history on file: 17, FY2009 to FY2025, as filed.

LMATLeMaitre Vascular, Inc.

Healthcare

$84.41-2.1% 1Y

$84.41

$78.6652 weeks$117.10

Is it growing?

Excellent

Growing: revenue growing +12% year on year, earnings up +39% year on year, and operating margin widening (+6.2 points).

3 good

Revenue trend+12% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +12% a year.

Earnings trend+39% in a year

Trailing-twelve-month earnings per share against a year earlier. Growing faster than revenue, so margins or the share count are helping.

Margin direction+6.2 points operating

Trailing-twelve-month operating margin, 29.5% now against 23.3% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

Revenue growth, 3 yearsbetter than 77% of the market

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is LMAT growing?

LeMaitre Vascular, Inc.'s revenue has grown 14% a year over three years, and grown 12% a year over five, with earnings per share compounding at 36%.

+14%

Revenue growth, 3-year annual rate · Medical Instruments & Supplies median +9.4% · steady growth, ahead of inflation · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +12%
Revenue growth, 5-year rate · +14% over three · growth has picked up over the last three years
Earnings per share, 3-year rate: +36%
Earnings per share, 3-year rate · revenue +14% · earnings outgrew revenue: margins or the share count worked for shareholders
Years of annual history on file: 17
Years of annual history on file · FY2009 to FY2025, as filed